
Sign up to save your podcasts
Or


James R. Copland joins Brian Anderson to discuss how America's uniquely cumbersome regulatory system impeded the national response to the Covid-19 crisis and how costly litigation could damage the economy even further.
The FDA and CDC's administrative failings in the early days of the crisis proved costly. The federal process for reviewing and approving drugs and medical devices, writes Copland, still leaves much to be desired. And a wave of coronavirus-related lawsuits poses a serious threat to future business viability.
By Manhattan Institute4.7
629629 ratings
James R. Copland joins Brian Anderson to discuss how America's uniquely cumbersome regulatory system impeded the national response to the Covid-19 crisis and how costly litigation could damage the economy even further.
The FDA and CDC's administrative failings in the early days of the crisis proved costly. The federal process for reviewing and approving drugs and medical devices, writes Copland, still leaves much to be desired. And a wave of coronavirus-related lawsuits poses a serious threat to future business viability.

3,314 Listeners

2,281 Listeners

706 Listeners

1,843 Listeners

1,402 Listeners

5,177 Listeners

4,888 Listeners

497 Listeners

6,622 Listeners

2,018 Listeners

2,837 Listeners

797 Listeners

1,228 Listeners

1,045 Listeners

1,091 Listeners